Background: Increasing evidence suggests that metabolism affects brain physiol-
because of the use of GLP-1 receptor agonists (GLP-1RA) in clinical practice and the associated body weight reduction. GLP-1 is secreted after food ingestion by the enteroendocrine L cells located in the distal jejunum and ileum. 13 Besides stimulating insulin secretion and inhibiting glucagon release, GLP-1 reduces food intake and enhances satiety by modulating brain mechanisms that control eating behaviour. 14 We recently tested the influence of exenatide, a GLP-1 agonist, on brain metabolism 15 and observed a marked increase of cerebral glucose uptake within few minutes after exenatide infusion. Moreover, we recently analysed the effect of GLP-1 on hypothalamic responses to food cues, measured as functional Magnetic Resonance
Imaging (fMRI) responses to visual stimuli containing food or nonfood images. We found that exenatide reduced the preference for food cues in the hypothalamus, and more so in obese than in lean observers. 16 Consistent with a central satiating effect of GLP-1, van
Bloemendaal et al 17 reported a decreased preference for food pictures in the insula, amygdala, putamen, and orbitofrontal cortex following short-term administration of a GLP-1RA in obese individuals. After
Roux-en-Y gastric bypass (RYGB), obese T2DM subjects show increased activation in the fusiform gyrus, somatosensory cortex, and frontal middle gyrus along with a marked increase in plasma GLP-1 level. 18, 19 Although some of these studies have employed visual images as food cues, most have focused on brain areas (gustation, reward, and executive functions), which respond differentially to food versus nonfood stimuli, [20] [21] [22] and no study has examined the modulation of the early sensory response to visual images (irrespective of their food/nonfood content) in cortical visual areas.
Vision plays an important role in food selection in humans. 23, 24 The sight of food elicits a variety of reactions ranging from anticipatory responses to food ingestion-ie, the cephalic phase of insulin release and heart rate changes 25, 26 -to a cascade of cognitive processes, involving memory and emotion 27 as well as executive function, eg, resisting the temptation of palatable food. 28, 29 Thus, a change of responsivity in early visual areas could trigger a cascade of effect potentially impacting food appreciation and food-related behaviours.
To test this hypothesis, here we ask whether exenatide is able to influence the basic physiology of early visual areas, irrespectively of the content of visual images (food related or otherwise).
To address this question, a new analysis based on a novel approach has been performed on data from a previous study. 16 First, rather than focusing on deep-brain structures involved in feeding behaviour (eg, hypothalamus), we examine the effects of exenatide over the entire cortical surface. Second, our analysis is not limited to assessing the effects of exenatide on the preference for food cues that many brain areas display, but it allows us to assess the effects of exenatide on cortical activity, irrespective of stimulus type-an aspect that has not been addressed in the prior study, or any previous work.
| MATERIALS AND METHODS
The study population included 10 lean participants and 10 obese nondiabetic participants, matched for age, gender, and fasting plasma glucose concentration. Participants received a 75-g OGTT 5 to 14 days before MRI session for appropriate classification of glucose regulation.
Obese subjects had higher BMI and fasting plasma insulin concentration ( Figure 1A ). were performed and two brain fMRI datasets acquired starting 30 min after the beginning of each infusion. During exenatide infusion, plasma glucose levels were measured at 5-minute interval, and a variable dextrose (20%) intravenous infusion was administered to three lean subjects and two obese subjects to maintain plasma glucose concentration constant at the fasting level ( Figure 1B 
| MR IMAGE ACQUISITION AND ANALYSIS
All image data were acquired with a 3-T, research-dedicated Siemens The results were registered to the participant's anatomy in FreeSurfer and projected to the individual surface after smoothing with a 5-mm full width at half maximum (FWHM) Gaussian kernel. Finally, data from all subjects and runs were projected to the fsaverage_sym surface, and corresponding vertices of the two hemispheres were averaged. Thus, after averaging across hemispheres, each vertex of this surface has 20 (subjects) × 2 (conditions: saline/exenatide) values of our three parameters: resting BOLD, food responses, and nonfood responses. These were analysed with an ANOVA for repeated measures, with between factor "obesity" (lean/obese) and within factors "condition" (saline/exenatide) and "image type" (food/nonfood), followed by post hoc t tests (two-sample t tests investigating the differences between obese and lean subjects; paired t tests investigating the differences between saline and exenatide or between food and nonfood pictures; one-sample t tests to identify voxels with significant visual responses, ie, nonzero percent signal change in response to any image, food, or nonfood; in all cases, P values are two-tailed).
In this way, each vertex of the fsaverage_sym pseudohemisphere is assigned with a F or t value, which are shown on its inflated and flattened view of the cortical surface (see Figure 2) , after thresholding to show values with P < .001 uncorrected. 
| Effects of exenatide and body weight on visual stimuli
We analysed fMRI data from a previous study 16 specifically testing the effect of exenatide on visual responses measured over the cortical surface of lean and obese subjects. Figure 2A represents the alignment of all participants to a template cortical map with predefined regions of interest that allows for morphing the pattern of sulci and gyri to match a standard atlas and achieve an excellent interindividual alignment of all the main cortical areas.
In Figure 2B , the map is colour-coded to show visual responses by averaging the percent signal change in response to food and nonfood pictures, with or without exenatide and pooling obese and lean subjects. As expected, responses (defined using a threshold two-tailed P value of .001, uncorrected) were primarily located in the occipital cortex and in the portion of the temporal lobe hosting the ventral visual pathway. Figure 2C shows the results of paired t tests comparing activity in response to food vs nonfood pictures (averaged across exenatide and saline experiments and pooled for subject groups). Fusiform, temporal, and limbic areas displayed preference for food pictures over nonfood images (at the same threshold of two-tailed P < .001). The opposite was seen in early visual cortex V1 and V2, where a preference for nonfood pictures was apparent, likely related to differences in the low-level visual statistics of the two image sets.
Having established these basic patterns of responses, we determined the effects of the variables of interest: ie, exenatide infusion, obesity, and their interactions. Figure 2D shows the results of paired t tests comparing visual responses during exenatide vs saline (irrespective of image type). The temporal pole showed a decrease of response to visual stimuli with exenatide, whereas the opposite was seen in several small cortical patches located in extrastriate occipital areas.
No cluster of vertices consistently showed an effect of body weight or an interaction between body weight and exenatide (maps not shown).
To gain better insight into the trends shown in Figure 2 , we proceed with a ROI-based approach (Figure 3 
| Effects of exenatide and body weight on BOLD signal at rest
The standard approach in fMRI limits analyses to BOLD responses, defined as percent signal changes relative to rest periods, with no FIGURE 3 ROI-based approach showing the effects of image type, exenatide, and obesity on percent signal change in the four regions of interest defined in Figure 2A consideration for the average BOLD signal at rest. This signal depends primarily on the MR acquisition settings; however, EPI contrast (ie, MR contrast used for fMRI) has been reported to be affected by physiological parameters such as vasodilation and cerebral blood flow. 35 We reasoned that these physiological parameters might well covary with obesity and exenatide, and we adopted the same statistical approach used for Figures 2B to 2D and 3 to analyse the effects of obesity and exenatide on the raw fMRI signal during periods of rest (no visual stimulus). Figure 2E shows that resting BOLD was higher during exenatide infusion than during saline infusion (each vertex in the map reports a t value obtained with a paired t test comparing resting BOLD with exenatide and saline in all 20 participants; threshold for significance is set to P < .001 uncorrected). Although the difference is significant across a large cortical territory, it may still be regarded as regional as it clearly spares large territories in the frontal cortex. Figure 2F shows that resting BOLD was also lower in obese compared with lean subjects (the map shows two-sample t test comparing the resting BOLD at each vertex between obese and lean subjects, at two-tailed P < .001 uncor- 
| DISCUSSION
This study goes beyond our previous work, which showed that exenatide affects the preference for food over nonfood pictures in deep brain structures including the hypothalamus 16 and demonstrates regionally specific effects of exenatide on cortical BOLD signals.
We observed a stimulus-selective effect of exenatide in the tem- on the contrary, these response changes reflect changes in the hemodynamic coupling that generates fMRI signal. Notably, in these same areas, exenatide also induces a large increase of the raw fMRI signal at rest, a variable that is not commonly analysed in fMRI studies. The absolute value of this parameter has no physiological meaning, as it mainly depends on the MR acquisition setting. However, we found regional variations of this value across consecutive acquisitions under identical settings. Specifically, during exenatide infusion, there was an increase of fMRI signal at rest that extends over a large cortical territory including the occipital lobe and sparing the frontal cortex. The signal covaried with BMI, and it was significantly lower in obese subjects.
Previous studies have focused on brain responses to visual food cues in areas involved in appetite and reward processing (insula, amygdala, orbitofrontal cortex, and striatum) demonstrating that obese individual, as compared with lean subjects, exhibits increased brain activation in bilateral insula, right amygdale, and orbitofrontal cortex. 36 Conversely, lean individuals have been shown to have greater activation of visual cortex in response to food cues than obese subjects. 37 However, Cornier et al did not fully explore the cortical pathways underlying visual evoked BOLD signal change within the cortex.
It is difficult to determine the physiologic basis of this finding.
Based on the few studies that have analysed the raw fMRI parameter in relation to physiological variables, we propose that this change might reflect a modulation of regional cerebral blood flow (rCBF), since this has been linked to the fMRI signal at rest, 38 and it is known to covary with BMI. 39 In particular, the impaired vasodilation previously reported in obese subjects 39, 40 could explain the reduction of CBF. Impaired vasodilation may also be the result of an inflammatory state, as it occurs in obesity and associated metabolic perturbations. [41] [42] [43] GLP-1 could ameliorate this dysfunction by affecting the inflammatory pathways and by modulating blood flow 44 through vasodilation, 45 systolic blood pressure, and sympathetic activity. 46 In this view, obesity would be associated with a decline in CBF that could be rescued by GLP-1 receptor activation. Moreover, given that CBF is closely coupled with glucose utilization in resting human brain, 47 the effect of exenatide on the raw fMRI BOLD signal could also reflect increased cerebral glucose uptake induced by exenatide as previously shown by ourselves. 15 Finally, the effect of exenatide on beta-cell function should be taken into account given the profound effect on brain metabolism and neural function of insulin. 48 We recognize that the sample size of our study is small, but, in spite of that, it was sufficient to reveal strong and reliable effects of exenatide. Notably, other recent studies with even smaller groups of diabetic patients did manage to highlight metabolic effects on brain activity. 49 We also acknowledge that the stimulus set employed In conclusion, the present study demonstrates that exenatide modulates BOLD visually evoked responses in cortical regions encoding the content of visual stimuli-food or nonfood related. In addition, exenatide and body weight affect the intensity of the raw fMRI signal at rest, which we speculatively associate with variations of CBF and/or glucose metabolism. We believe that our study expands the literature available suggesting an important impact of body weight on food cues brain responses, which is characterized by a complex modulation of multiple brain areas involved in visual stimuli processing that can be further acutely modulated by GLP-1 receptor activation.
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